154 related articles for article (PubMed ID: 1857341)
1. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
Tyndale RF; Sunahara R; Inaba T; Kalow W; Gonzalez FJ; Niznik HB
Mol Pharmacol; 1991 Jul; 40(1):63-8. PubMed ID: 1857341
[TBL] [Abstract][Full Text] [Related]
2. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
4. Human hepatic cytochrome P450 2D6-like activity in nonhuman primates: catalytic characterization in vitro.
Wu D; Otton SV; Morrow P; Inaba T; Kalow W; Sellers EM
J Pharmacol Exp Ther; 1993 Aug; 266(2):715-9. PubMed ID: 8355202
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
6. A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization.
Sakamoto K; Kirita S; Baba T; Nakamura Y; Yamazoe Y; Kato R; Takanaka A; Matsubara T
Arch Biochem Biophys; 1995 Jun; 319(2):372-82. PubMed ID: 7786018
[TBL] [Abstract][Full Text] [Related]
7. Substrate specificity of the form of cytochrome P-450 catalyzing the 4-hydroxylation of debrisoquine in man.
Boobis AR; Murray S; Kahn GC; Robertz GM; Davies DS
Mol Pharmacol; 1983 Mar; 23(2):474-81. PubMed ID: 6220203
[TBL] [Abstract][Full Text] [Related]
8. In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver.
Otton SV; Brinn RU; Gram LF
Drug Metab Dispos; 1988; 16(1):15-7. PubMed ID: 2894945
[TBL] [Abstract][Full Text] [Related]
9. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD
Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501
[TBL] [Abstract][Full Text] [Related]
10. The in vitro interaction of dexmedetomidine with human liver microsomal cytochrome P4502D6 (CYP2D6).
Rodrigues AD; Roberts EM
Drug Metab Dispos; 1997 May; 25(5):651-5. PubMed ID: 9152607
[TBL] [Abstract][Full Text] [Related]
11. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
[TBL] [Abstract][Full Text] [Related]
12. Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22.
Gonzalez FJ; Vilbois F; Hardwick JP; McBride OW; Nebert DW; Gelboin HV; Meyer UA
Genomics; 1988 Feb; 2(2):174-9. PubMed ID: 3410476
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a rat liver cytochrome P-450UT-H cDNA clone and comparison of mRNA levels with catalytic activity.
Churchill PF; Churchill SA; Martin MV; Guengerich FP
Mol Pharmacol; 1987 Feb; 31(2):152-8. PubMed ID: 3543648
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives.
Lomenzo SA; Izenwasser S; Katz JL; Terry PD; Zhu N; Klein CL; Trudell ML
J Med Chem; 1997 Dec; 40(26):4406-14. PubMed ID: 9435910
[TBL] [Abstract][Full Text] [Related]
16. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, expression, and characterization of CYP2D17 from cynomolgus monkey liver.
Mankowski DC; Laddison KJ; Christopherson PA; Ekins S; Tweedie DJ; Lawton MP
Arch Biochem Biophys; 1999 Dec; 372(1):189-96. PubMed ID: 10562433
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
20. Mepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms.
Hiroi T; Ohishi N; Imaoka S; Yabusaki Y; Fukui H; Funae Y
J Pharmacol Exp Ther; 1995 Feb; 272(2):939-44. PubMed ID: 7853212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
